Alamar Biosciences launches NULISA Dried Blood Spot Extraction Kit for home-collected fingerstick samples (bioanalysis-zone.com)

• Alamar launches NULISA DBS Extraction Kit for fingerstick microsamples.
• Compatible with third-party devices: Capitainer, Telimmune, Mitra, Tasso.
• 85–95% target detectability in CNS and Inflammation panel validation.
• Enables decentralized, longitudinal study designs without venous draws.

"Alamar Biosciences (Nasdaq: ALMR) has announced the launch of its NULISA Dried Blood Spot (DBS) Extraction Kit, enabling researchers to run NULISA multiplex protein panels on microsamples collected at home via fingerstick. The kit standardizes extraction across several third-party devices (Capitainer, Telimmune, Mitra, Tasso), achieving 85–95% target detectability on CNS and Inflammation panels in validation studies. This allows decentralized, longitudinal study designs in neurology, inflammation, and population health without venous blood draws."